Present Status of Antithrombotic Therapy in Acute Heart Attack

Publisher Website
Google Scholar
Abstract
Pharmacologic candidates for prophylaxis and therapy against coronary thrombosis include platelet antiaggregants, anticoagulants, and thrombolytic agents. As understanding of the mechanisms of thrombogenesis and thrombolysis increases, so does the ability to anticipate when and how these agents can be expected to be effective. Current trials of the thrombolytic agents are viewed in this context.

This publication has 4 references indexed in Scilit: